Literature DB >> 22618998

How well do commonly used data presentation formats support comparative effectiveness evaluations?

James G Dolan1, Feng Qian2, Peter J Veazie1.   

Abstract

BACKGROUND: Good decisions depend on an accurate understanding of the comparative effectiveness of decision alternatives. The best way to convey data needed to support these comparisons is unknown.
OBJECTIVE: To determine how well 5 commonly used data presentation formats convey comparative effectiveness information.
METHODS: The study was an Internet survey using a factorial design. Participants consisted of 279 members of an online survey panel. Study participants compared outcomes associated with 3 hypothetical screening test options relative to 5 possible outcomes with probabilities ranging from 2 per 5000 (0.04%) to 500 per 1000 (50%). Data presentation formats included a table, a "magnified" bar chart, a risk scale, a frequency diagram, and an icon array. Outcomes included the number of correct ordinal judgments regarding the more likely of 2 outcomes, the ratio of perceived versus actual relative likelihoods of the paired outcomes, the intersubject consistency of responses, and perceived clarity.
RESULTS: The mean number of correct ordinal judgments was 12 of 15 (80%), with no differences among data formats. On average, there was a 3.3-fold difference between perceived and actual likelihood ratios (95% confidence interval = 3.0-3.6). Comparative judgments based on flowcharts, icon arrays, and tables were all significantly more accurate and consistent than those based on risk scales and bar charts (P < 0.001). The most clearly perceived formats were the table and the flowchart. Low subjective numeracy was associated with less accurate and more variable data interpretations and lower perceived clarity for icon displays, bar charts, and flow diagrams.
CONCLUSIONS: None of the data presentation formats studied can reliably provide patients, especially those with low subjective numeracy, with an accurate understanding of comparative effectiveness information.

Entities:  

Mesh:

Year:  2012        PMID: 22618998      PMCID: PMC3515653          DOI: 10.1177/0272989X12445284

Source DB:  PubMed          Journal:  Med Decis Making        ISSN: 0272-989X            Impact factor:   2.583


  31 in total

1.  Influence of data display formats on physician investigators' decisions to stop clinical trials: prospective trial with repeated measures.

Authors:  L S Elting; C G Martin; S B Cantor; E B Rubenstein
Journal:  BMJ       Date:  1999-06-05

2.  Strategies to help patients understand risks.

Authors:  John Paling
Journal:  BMJ       Date:  2003-09-27

3.  Simple tools for understanding risks: from innumeracy to insight.

Authors:  Gerd Gigerenzer; Adrian Edwards
Journal:  BMJ       Date:  2003-09-27

Review 4.  Cardiovascular proteomics: tools to develop novel biomarkers and potential applications.

Authors:  Sara Arab; Anthony O Gramolini; Peipei Ping; Thomas Kislinger; Brian Stanley; Jennifer van Eyk; Maral Ouzounian; David H MacLennan; Andrew Emili; Peter P Liu
Journal:  J Am Coll Cardiol       Date:  2006-10-17       Impact factor: 24.094

Review 5.  Numeric, verbal, and visual formats of conveying health risks: suggested best practices and future recommendations.

Authors:  Isaac M Lipkus
Journal:  Med Decis Making       Date:  2007-09-14       Impact factor: 2.583

Review 6.  Rethinking health numeracy: a multidisciplinary literature review.

Authors:  Jessica S Ancker; David Kaufman
Journal:  J Am Med Inform Assoc       Date:  2007-08-21       Impact factor: 4.497

Review 7.  Design features of graphs in health risk communication: a systematic review.

Authors:  Jessica S Ancker; Yalini Senathirajah; Rita Kukafka; Justin B Starren
Journal:  J Am Med Inform Assoc       Date:  2006-08-23       Impact factor: 4.497

Review 8.  Informed consent: putting risks into perspective.

Authors:  A D Singh; J Paling
Journal:  Surv Ophthalmol       Date:  1997 Jul-Aug       Impact factor: 6.048

9.  Formats for improving risk communication in medical tradeoff decisions.

Authors:  Erika A Waters; Neil D Weinstein; Graham A Colditz; Karen Emmons
Journal:  J Health Commun       Date:  2006-03

10.  Measuring numeracy without a math test: development of the Subjective Numeracy Scale.

Authors:  Angela Fagerlin; Brian J Zikmund-Fisher; Peter A Ubel; Aleksandra Jankovic; Holly A Derry; Dylan M Smith
Journal:  Med Decis Making       Date:  2007-07-19       Impact factor: 2.583

View more
  10 in total

1.  A process for creating data report-back tools to improve equity in environmental health.

Authors:  Kathryn S Tomsho; Erin Polka; Stacey Chacker; David Queeley; Marty Alvarez; Madeleine K Scammell; Karen M Emmons; Rima E Rudd; Gary Adamkiewicz
Journal:  Environ Health       Date:  2022-07-12       Impact factor: 7.123

2.  Do visual aids influenced patients' risk perceptions for rare and very rare risks?

Authors:  Liana Fraenkel; Valerie Reyna; Raluca Cozmuta; Diana Cornell; Julia Nolte; Evan Wilhelms
Journal:  Patient Educ Couns       Date:  2018-06-20

3.  Attitude to health risk in the Canadian population: a cross-sectional survey.

Authors:  Nick Bansback; Mark Harrison; Mohsen Sadatsafavi; Anne Stiggelbout; David G T Whitehurst
Journal:  CMAJ Open       Date:  2016-06-03

4.  Who should decide how much and what information is important in person-centred health care?

Authors:  Mette Kjer Kaltoft; Jesper Bo Nielsen; Glenn Salkeld; Jack Dowie
Journal:  J Health Serv Res Policy       Date:  2015-01-10

5.  Use of the analytic hierarchy process for medication decision-making in type 2 diabetes.

Authors:  Nisa M Maruthur; Susan M Joy; James G Dolan; Hasan M Shihab; Sonal Singh
Journal:  PLoS One       Date:  2015-05-22       Impact factor: 3.240

6.  Increasing User Involvement in Health Care and Health Research Simultaneously: A Proto-Protocol for "Person-as-Researcher" and Online Decision Support Tools.

Authors:  Mette Kjer Kaltoft; Jesper Bo Nielsen; Glenn Salkeld; Jack Dowie
Journal:  JMIR Res Protoc       Date:  2014-11-25

7.  Development of a Framework Based on Reflective MCDA to Support Patient-Clinician Shared Decision-Making: The Case of the Management of Gastroenteropancreatic Neuroendocrine Tumors (GEP-NET) in the United States.

Authors:  Monika Wagner; Dima Samaha; Hanane Khoury; William M O'Neil; Louis Lavoie; Liga Bennetts; Danielle Badgley; Sylvie Gabriel; Anthony Berthon; James Dolan; Matthew H Kulke; Mireille Goetghebeur
Journal:  Adv Ther       Date:  2017-12-21       Impact factor: 3.845

8.  The value of personalised risk information: a qualitative study of the perceptions of patients with prostate cancer.

Authors:  Paul K J Han; Norbert Hootsmans; Michael Neilson; Bethany Roy; Terence Kungel; Caitlin Gutheil; Michael Diefenbach; Moritz Hansen
Journal:  BMJ Open       Date:  2013-09-13       Impact factor: 2.692

9.  Systematic assessment of benefits and risks: study protocol for a multi-criteria decision analysis using the Analytic Hierarchy Process for comparative effectiveness research.

Authors:  Nisa M Maruthur; Susan Joy; James Dolan; Jodi B Segal; Hasan M Shihab; Sonal Singh
Journal:  F1000Res       Date:  2013-07-24

10.  Risk communication in tables versus text: a registered report randomized trial on 'fact boxes'.

Authors:  Cameron Brick; Michelle McDowell; Alexandra L J Freeman
Journal:  R Soc Open Sci       Date:  2020-03-25       Impact factor: 2.963

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.